Week In Review: Sinopharm Transfers $4.6 Billion In Assets, Including Two COVID-19 Vaccines
April 17, 2021 at 14:00 PM EDT
Sinopharm Group will transfer six of its vaccine companies to Beijing Tiantan Biological Products. Two of the transferring companies have approved COVID-19 vaccines, and Sinopharma said a public listing will facilitate additional sources of funding.